Datavant to acquire Aetion.

Datavant, a health data platform company, agreed to acquire Aetion, a real-world evidence platform that powers critical decision-making in healthcare. Financial terms were not disclosed. “As Datavant has grown and scaled, our life sciences and ecosystem partners have been asking us for a deeper capability set to bring together disparate data sources so they can tap into a more comprehensive and longitudinal view of patient health across the product lifecycle. The addition of Aetion’s team of scientists and technologists further bolsters our complementary capabilities and expertise so we can better leverage data from our ecosystem of partners to support efforts before, during, and after commercialization - generating evidence from trial to treatment and beyond to deliver life-improving therapies,” Kyle Armbrester, Datavant CEO.